catalent glp 1 JPM24: poised to pounce on GLP-1 manufacturing opportunity, CEO says keeping the weight off can be complicated Backlash builds against Novo's Catalent

Patients using GLP-1 therapies for weight loss often have different expectations and motivations compared to those using them for diabetes

Studies investigate the peptide's effects on NF-B activation and cytokine production profiles in inflammatory conditions

Second, senior canine physiology shares meaningful overlap with human aging: declining tissue repair capacity, increased inflammatory burden, joint cartilage degradation, and cognitive decline patterns all present similarly in aging dogs and aging humans

Many people will be able to get enough vitamin B12 from a balanced diet

Are things trending better, staying the same, or getting worse